Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
B3GALT6	beta3GalT6	ENSG00000176022	"Beta-1,3-galactosyltransferase 6"	Q96L58	1	1232265-1235041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.76e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-2)"	12.2	9.4	13.4	9.9	11.7	3.0	10.2	10.3	17.2	10.0	7.5	11.1	9.5	7.2	11.9	9.3	7.7	11.9	7.1	12.6	13.7	12.9	9.8	19.5	10.1	12.3	9.4	7.9	11.4	14.7	14.1	10.4	12.3	10.4	9.6	6.0	11.4	9.9	8.7	9.6	13.4	7.0	9.3	8.4	12.9	9.2	8.4	10.8	14.7	10.1	7.0	7.7	8.2	9.0	5.2	5.1	2.9	4.1	6.0	6.6	2.2	10.6	5.4	9.3	9.7	9.4	6.4	7.2	11.4	9.7	9.6	7.8	4.8	10.9	8.0	6.8	6.7	8.3	9.6	4.0	6.1	5.9	14.0	15.2	14.8	5.4	4.5	9.7	9.1	9.4	5.9	4.5	6.3	6.2	5.8	7.2	9.3	10.3	7.2	9.7	6.1	12.4	16.5	12.0	11.2	20.5	11.9	3.7	6.5	9.4	3.3	38.3	15.7	8.4	10.0	5.7	5.7	8.4	13.2	7.7	9.9	4.4	6.2	16.3	4.5	3.8	7.3	7.8	20.6	11.2	2.9	2.8	0.9	3.8	3.5	6.6	3.1	3.9	4.5	3.8	5.2	3.4	4.1	1.4	6.0	4.1	5.1	1.6	2.2	13.4	11.7	10.3	17.2	13.7	12.9	9.4	7.9	10.4	10.8	11.9	6.9	8.3	19.2	7.4	12.1	6.4	7.6	2.7	3.4	12.2	3.9	1.4	6.6	7.4	0.4	9.6	1.6	0.0	10.7	3.0	6.2	12.4	0.0	10.5	6.3	19.1	5.8	7.4	7.5	0.9	2.6	7.2	1.7	1.0	3.9	8.2	9.0	0.0	3.9	9.9	8.3	0.0	6.2	1.4	2.7	11.0	1.1	6.9	4.4	9.5
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134411918	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 76.0"	"Cell type enhanced"	"Detected in some"	30	"Bipolar cells: 34.2;Horizontal cells: 22.3;Muller glia cells: 119.7"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.8;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	39	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.4;HMC-1: 19.3;NTERA-2: 16.7;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468, HPA074314"	Enhanced		Enhanced	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	1.5	5.8	38.9	1.7	23.7	2.1	5.6	9.2	76.0	1.7	1.5	25.8	0.0	1.8	1.6	1.7	1.4	1.6	1.7	1.5	43.4	14.9	2.1	6.0	1.8	3.3	30.3	19.5	1.5	1.7	1.4	0.9	1.4	19.7	4.2	1.5	2.1	2.2	1.8	1.4	1.8	1.6	1.5	45.1	2.1	6.0	1.8	25.2	0.0	7.7	0.0	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	3.0	0.0	0.7	0.9	1.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	16.7	0.8	0.0	0.3	0.0	1.2	0.0	0.1	2.3	6.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.8	1.9	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.4	38.9	23.7	9.2	33.7	43.4	14.9	30.3	19.5	19.7	25.2	0.0	0.0	0.0	0.0	0.0	34.2	1.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.9	0.1	22.3	1.7	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	119.7	0.0	0.0	0.4	2.3	6.3	0.0	0.0	0.2	0.1	0.0	0.1	3.2	0.0	0.1
B3GAT2	GlcAT-S	ENSG00000112309	"Beta-1,3-glucuronyltransferase 2"	Q9NPZ5	6	70856679-70957038	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 27.2"	"Cell type enriched"	"Detected in many"	9	"Horizontal cells: 301.9"	"Group enriched"	"Detected in some"	20	"glioma: 4.7;testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	20	"SCLC-21H: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012059	Uncertain					NA	NA					"HPA012059: AB_2061050"	"unprognostic (7.10e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.16e-4)"	"unprognostic (8.09e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.88e-7)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.45e-3)"	1.8	1.5	9.5	1.9	7.8	1.6	1.1	3.2	27.2	0.8	1.1	26.2	0.0	2.3	1.4	1.1	1.4	1.1	1.4	1.5	19.2	11.5	1.0	1.3	1.2	2.0	9.7	13.6	1.1	2.2	0.8	0.5	1.2	21.0	1.3	0.9	0.4	1.5	0.9	1.5	1.9	2.4	1.1	17.3	2.0	1.5	2.9	16.3	0.0	1.5	0.0	0.9	1.3	0.9	1.2	1.0	2.0	1.2	1.1	2.2	0.2	0.3	0.0	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.1	0.1	0.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.2	0.3	0.2	0.0	0.2	22.7	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	1.3	1.2	1.2	1.0	1.0	0.9	1.0	1.5	2.1	0.4	1.2	1.7	1.8	2.0	1.1	1.1	1.0	2.2	0.2	9.5	7.8	3.2	11.2	19.2	11.5	9.7	13.6	21.0	16.3	0.0	2.1	16.6	7.9	22.7	12.4	0.8	7.6	0.0	0.0	15.7	21.6	5.1	0.0	5.0	6.6	7.5	11.0	0.0	3.3	2.8	10.3	14.9	0.0	7.7	7.0	301.9	0.0	3.7	5.3	4.0	18.4	11.1	13.5	11.8	4.1	17.1	7.1	7.0	12.7	0.5	21.5	12.9	8.2	17.4	32.2	17.3	5.9	13.1	3.8	9.9
B3GAT3	GlcAT-I	ENSG00000149541	"Beta-1,3-glucuronyltransferase 3"	O94766	11	62615296-62622175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051328	Approved				"Intracellular and membrane"	NA	NA		1600000			"HPA051328: AB_2681444"	"unprognostic (1.55e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (4.94e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.58e-2)"	14.4	21.6	24.8	15.9	29.2	15.0	19.7	28.9	29.1	15.4	12.9	24.2	8.1	17.6	14.9	18.8	10.6	21.1	15.3	13.1	25.8	25.6	17.4	21.5	12.8	22.9	30.0	16.8	17.0	22.4	18.5	25.6	19.9	25.7	18.2	6.8	19.0	24.9	20.9	6.4	23.1	16.5	14.2	24.4	17.5	15.5	12.0	24.8	17.5	14.5	5.4	12.9	14.4	17.4	11.2	15.7	15.7	18.9	24.5	14.1	9.4	9.8	16.3	8.9	15.4	12.2	12.1	6.5	8.2	11.6	7.8	8.8	7.2	14.7	8.7	28.4	8.2	21.7	6.4	9.0	8.2	1.7	19.4	17.4	4.1	7.5	9.1	29.6	5.9	9.8	21.4	14.0	10.2	4.2	12.8	6.9	11.3	13.8	22.0	9.2	25.1	10.0	21.0	13.8	5.6	15.3	10.2	6.4	47.9	16.2	1.9	9.4	15.4	9.4	11.1	37.5	3.1	14.9	11.6	5.3	7.9	6.2	21.1	15.7	22.9	7.6	10.1	24.2	10.7	16.6	15.7	18.4	15.5	14.1	18.3	9.3	11.2	9.8	11.4	15.7	9.1	9.8	11.4	5.4	24.5	18.9	9.3	11.7	9.4	24.8	29.2	28.9	27.7	25.8	25.6	30.0	16.8	25.7	24.8	6.0	10.4	30.4	32.3	17.5	51.2	3.2	25.5	6.7	18.2	38.4	31.4	64.6	13.3	30.5	0.4	21.0	25.1	0.0	40.4	49.5	29.4	29.0	1.1	24.6	59.6	46.1	24.2	26.4	39.3	1.9	33.4	30.8	42.2	55.1	20.6	46.3	31.6	28.1	21.2	15.3	38.8	25.8	20.2	6.3	23.5	16.9	36.4	44.6	24.7	17.3
B4GALT7	"beta4Gal-T7, XGALT-1"	ENSG00000027847	"Beta-1,4-galactosyltransferase 7"	Q9UBV7	5	177600100-177610347	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042330	Supported					NA	NA					"HPA042330: AB_10796576"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	13.8	33.0	16.0	20.4	14.3	20.7	19.1	10.6	19.6	13.3	12.4	14.9	20.4	16.1	15.5	15.9	11.7	13.3	20.3	17.3	13.7	18.0	16.2	21.3	12.0	21.5	15.1	17.9	16.9	37.0	15.5	23.9	15.3	14.3	16.4	11.7	14.7	22.4	20.9	14.4	12.9	13.7	12.2	10.8	16.3	16.2	16.1	11.7	10.4	16.7	9.8	18.6	13.0	10.2	15.8	16.3	11.2	16.1	8.5	12.5	9.0	8.5	15.2	6.4	16.0	12.8	9.6	28.9	13.4	14.2	12.2	14.0	14.3	13.7	11.1	24.7	13.6	21.4	10.2	4.4	28.6	5.3	36.9	11.6	5.8	11.9	10.0	18.6	6.0	10.2	14.7	10.2	13.1	10.7	11.2	13.5	7.5	5.0	10.7	12.3	20.0	5.1	7.4	6.2	7.7	22.4	10.4	4.6	12.1	9.2	13.1	5.7	6.5	6.6	13.5	11.7	5.3	8.7	7.1	10.4	15.6	9.0	10.2	13.2	13.4	6.2	7.8	13.2	14.5	14.1	11.2	14.6	7.8	12.5	16.1	11.3	12.8	11.6	11.0	16.3	15.8	10.5	10.3	1.0	8.5	15.3	12.8	7.5	9.0	16.0	14.3	10.6	19.6	13.7	18.0	15.1	17.9	14.3	11.7	3.0	6.4	14.9	14.1	6.0	11.8	5.9	10.2	5.3	10.3	15.7	3.9	37.3	6.6	28.8	12.3	11.3	13.7	0.0	34.1	110.0	18.1	23.5	10.3	13.9	28.4	11.1	13.9	10.4	8.8	7.8	13.0	10.6	20.3	33.3	19.6	12.2	26.0	10.5	17.3	15.8	15.1	0.0	11.4	13.0	12.4	7.8	36.7	10.1	20.9	13.9
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538947-219543787	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 137.8;Extravillous trophoblasts: 162.1;Syncytiotrophoblasts: 259.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.96e-4)"	8.6	14.1	9.7	8.4	11.8	1.4	6.8	8.5	19.4	22.1	8.6	11.3	23.0	18.4	17.0	24.6	7.9	9.2	17.1	36.3	12.2	10.7	11.3	52.1	11.6	5.4	9.0	10.5	38.1	60.7	16.3	36.9	62.7	10.4	19.3	3.8	27.4	31.6	19.9	4.3	9.0	13.3	9.1	8.3	4.5	15.6	34.2	7.0	3.8	17.9	7.4	10.6	11.9	8.5	1.3	11.1	6.9	0.1	2.1	3.0	0.8	18.8	3.7	2.8	23.5	10.7	16.9	32.2	19.1	16.2	5.4	5.0	10.4	16.6	5.9	41.2	18.5	18.6	24.1	1.8	11.5	0.8	9.1	6.5	2.1	5.3	45.1	15.0	1.8	12.4	22.6	20.4	5.5	5.3	19.7	0.0	2.0	13.0	14.4	5.1	29.5	0.2	4.9	11.6	6.4	14.5	0.0	8.9	11.5	6.5	8.5	6.9	10.6	9.2	9.0	26.2	5.5	3.0	6.4	0.4	20.1	11.0	24.0	9.9	17.4	5.3	2.7	18.4	1.9	20.3	2.1	0.0	6.9	2.4	0.1	3.0	1.3	1.9	1.6	0.0	0.1	2.2	0.8	0.0	2.1	0.0	11.1	1.2	0.8	9.7	11.8	8.5	19.4	12.2	10.7	9.0	10.5	10.4	7.0	0.0	14.6	4.5	19.1	12.9	13.8	27.7	25.5	2.7	6.8	71.5	9.8	137.8	8.3	48.8	3.2	3.5	16.9	0.0	70.1	162.1	52.1	34.2	10.3	49.9	16.5	41.3	41.2	6.7	1.3	5.7	23.0	2.8	64.1	2.8	36.9	62.9	60.3	26.6	59.4	16.4	11.4	25.8	16.5	11.6	5.5	9.7	259.5	7.5	11.3	28.6
CHPF2	"ChSy-3, CSGlcA-T, KIAA1402"	ENSG00000033100	"Chondroitin polymerizing factor 2"	Q9P2E5	7	151232489-151238827	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020992	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA020992: AB_1847267"	"unprognostic (8.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (4.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.59e-3)"	13.5	29.3	13.4	19.0	12.9	22.6	19.1	13.1	20.2	15.3	14.4	11.4	20.7	14.9	19.5	16.9	13.3	14.9	17.6	18.8	13.7	12.5	14.9	20.7	17.4	23.4	11.4	17.4	14.4	23.7	16.7	41.5	18.6	11.8	18.5	10.8	12.2	25.4	19.8	7.9	14.2	17.1	17.3	9.4	28.1	20.1	12.9	11.1	16.2	17.5	7.4	13.7	18.9	12.8	2.7	9.5	9.9	5.6	2.6	5.7	3.7	9.0	7.4	5.0	14.5	17.4	17.3	7.5	19.1	29.8	10.4	12.7	4.9	15.4	2.7	33.8	30.3	14.2	11.4	2.2	13.6	4.5	10.4	6.8	2.9	8.1	6.8	16.3	5.8	24.2	26.4	7.7	9.8	3.5	21.6	16.3	4.6	2.7	8.0	16.5	14.9	5.4	22.9	6.6	3.8	8.6	5.1	2.9	9.1	10.1	7.2	5.4	9.6	10.2	10.1	4.8	3.9	3.9	9.6	22.2	11.6	1.9	15.3	16.1	14.8	2.1	4.0	42.1	7.8	15.6	1.2	5.6	7.9	5.7	5.1	5.4	2.7	3.1	5.1	6.3	2.7	2.2	2.3	9.9	2.6	5.0	9.5	3.4	3.7	13.4	12.9	13.1	20.2	13.7	12.5	11.4	17.4	11.8	11.1	8.9	10.2	11.5	4.8	4.0	9.5	1.6	12.7	4.0	4.5	10.4	3.9	9.1	1.7	10.3	0.5	4.7	10.2	23.3	14.5	12.1	9.7	9.5	5.8	8.3	11.2	23.8	8.1	13.5	11.6	0.7	15.8	8.5	6.8	7.2	10.1	4.3	14.8	15.9	14.2	3.3	6.9	19.4	6.2	3.4	1.7	3.9	8.6	12.1	8.1	8.9
CHST11	"C4ST, C4St-1, C4ST1, HSA269537"	ENSG00000171310	"Carbohydrate sulfotransferase 11"	Q9NPF2	12	104455295-104762014	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 55.7;monocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052828	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		22000	"Golgi apparatus"		"HPA052828: AB_2681966"	"unprognostic (6.35e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (7.59e-11)"	"unprognostic (1.64e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (8.42e-4)"	6.7	14.3	14.6	21.6	16.6	37.3	4.9	5.7	16.1	6.6	6.2	8.2	9.7	3.9	15.7	16.1	4.4	5.2	11.1	6.6	13.4	11.9	4.4	4.0	15.3	22.5	11.5	6.7	8.7	6.3	1.9	6.8	17.2	10.0	6.4	5.2	16.1	3.3	13.4	1.7	2.7	7.7	12.6	10.5	17.5	8.3	3.3	11.8	26.5	4.3	2.9	15.6	8.5	5.3	2.0	2.6	13.8	1.3	1.3	2.8	0.6	13.5	6.2	2.9	1.8	7.3	3.6	10.2	1.2	0.4	0.6	0.5	0.0	17.7	0.0	2.0	1.8	14.9	3.4	1.7	7.1	0.7	0.1	2.5	18.0	1.6	0.0	1.1	21.0	21.4	1.3	1.0	11.5	1.9	10.8	4.5	25.8	27.8	4.6	1.2	3.3	16.0	24.7	2.4	0.1	2.3	18.2	9.6	4.5	6.0	0.1	4.9	8.0	0.8	9.2	17.0	2.6	2.7	21.3	10.4	2.0	2.2	10.3	11.2	24.0	25.8	3.4	9.4	14.8	20.1	9.3	1.3	9.4	2.8	1.2	1.6	0.9	1.5	2.1	0.7	2.0	0.7	1.8	13.8	1.3	1.1	2.6	2.8	0.6	14.6	16.6	5.7	10.4	13.4	11.9	11.5	6.7	10.0	11.8	14.9	13.3	17.2	13.2	2.5	1.6	4.5	2.5	4.0	7.9	5.2	0.0	28.8	0.0	5.0	0.6	6.3	0.0	0.0	55.7	12.0	9.1	2.7	41.4	0.4	42.1	9.5	0.0	22.1	23.7	1.1	6.9	35.3	3.3	81.2	0.0	1.6	21.1	0.0	15.9	4.8	0.5	6.5	7.2	0.5	2.7	2.5	22.2	36.2	0.0	2.4
CHST12	"C4S-2, C4ST2"	ENSG00000136213	"Carbohydrate sulfotransferase 12"	Q9NRB3	7	2403560-2448483	"Enzymes, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ito cells: 159.0;T-cells: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 26.2;NB-4: 27.1;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041680	Approved		Approved	"Golgi apparatus"		NA	NA		430000	"Golgi apparatus"		"HPA041680: AB_10959789"	"unprognostic (4.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.32e-5)"	"unprognostic (9.61e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	24.2	12.0	9.4	12.1	10.5	14.5	11.2	17.8	16.5	11.9	10.1	13.2	9.0	13.5	14.4	10.6	5.9	11.7	10.9	12.0	8.8	7.7	9.3	6.8	13.6	10.3	10.4	9.2	9.6	17.5	4.9	14.4	9.6	12.7	11.8	4.2	12.3	14.1	11.6	11.9	11.5	10.1	8.1	9.5	25.0	12.4	10.2	8.6	9.0	11.2	4.4	11.8	10.6	10.3	5.7	21.0	16.4	3.5	37.4	30.2	6.7	3.9	4.0	2.5	4.5	3.7	2.7	12.7	7.2	3.4	3.1	4.3	4.5	1.5	3.5	13.6	3.2	6.8	3.2	1.6	1.9	0.9	4.6	8.5	2.4	3.5	5.0	1.7	8.0	26.2	3.7	1.2	2.8	0.3	3.2	3.2	5.9	6.2	12.7	1.4	3.6	8.4	27.1	8.5	1.2	7.3	3.1	3.3	18.3	1.5	2.1	3.0	12.5	3.5	2.6	1.8	2.5	3.3	10.2	5.4	4.6	12.0	9.0	6.3	38.6	14.9	1.6	3.7	4.1	7.9	15.5	3.5	16.4	30.2	2.8	18.9	5.2	10.7	24.5	6.6	5.7	4.5	13.5	1.0	37.4	1.2	21.0	10.2	6.7	9.4	10.5	17.8	16.5	8.8	7.7	10.4	9.2	12.7	8.6	14.9	44.5	41.3	35.2	16.1	44.3	6.7	10.2	17.4	30.7	17.4	62.8	84.2	1.7	17.6	4.4	44.9	6.7	23.3	13.5	8.5	48.9	15.3	36.9	5.9	22.1	44.5	12.2	159.0	21.8	2.7	88.6	20.1	20.3	17.2	9.4	16.0	13.1	7.0	63.6	10.3	46.4	19.4	19.6	27.6	19.4	13.4	111.7	128.5	13.1	9.1
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524283-126543291	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.8;liver: 42.5"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 56.2;Hepatocytes: 33.7;Spermatocytes: 29.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 46.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 46.8"	"Group enriched"	"Detected in some"	8	"CACO-2: 12.5;Hep G2: 22.4;NB-4: 14.9;THP-1: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA067960			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA067960: "	"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.5	0.2	0.2	0.5	0.3	0.9	0.0	0.2	0.6	0.1	0.9	0.1	0.0	0.8	0.0	1.1	0.1	0.1	0.2	1.1	0.2	0.1	2.6	42.5	0.6	0.6	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.6	0.5	0.1	0.3	0.0	1.8	0.0	0.3	2.9	0.6	9.7	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	7.0	46.8	10.6	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	10.6	46.8	0.0	6.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	9.8	0.0	5.2	0.0	0.0	3.6	0.2	0.3	0.2	0.6	0.2	0.1	0.3	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	12.3	0.0	1.2	1.3	7.6	3.8	1.4	3.2	0.0	0.0	0.9	0.0	0.0	2.9	1.1	7.9	0.0	0.0	0.0	29.3	2.7	0.0	0.2	0.0	1.6	0.0
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470998-40474571	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 39.3;Extravillous trophoblasts: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057697, HPA071601"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA057697: AB_2683505, HPA071601: AB_2686425"	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	10.3	7.9	7.1	7.5	6.9	2.3	22.7	6.5	7.4	14.9	7.9	6.0	13.8	3.6	17.5	11.1	6.5	12.3	14.1	12.6	5.5	2.9	8.1	9.6	15.9	20.9	8.1	4.5	18.8	11.6	10.2	11.4	22.4	7.1	10.7	3.8	9.8	12.7	17.2	5.5	6.8	7.1	13.3	5.9	10.5	7.3	9.2	6.3	7.5	12.4	8.3	6.1	12.1	18.2	2.1	3.4	8.0	1.9	5.5	4.0	1.1	10.6	7.0	11.3	30.4	17.7	13.7	17.6	10.5	20.0	18.6	17.7	8.5	5.4	1.7	16.1	17.8	33.0	18.3	10.0	5.9	8.8	12.7	5.8	5.4	7.5	8.1	9.6	2.3	14.2	16.7	4.9	6.5	5.0	20.6	16.3	6.3	5.3	6.4	13.8	8.0	3.8	12.2	7.2	3.2	8.2	10.7	14.3	3.0	12.4	5.5	8.2	12.5	9.2	10.4	3.4	14.4	15.1	9.8	13.3	31.6	11.7	9.9	10.4	12.9	8.9	4.9	14.2	8.0	22.7	8.0	1.9	3.6	4.0	1.9	1.1	0.5	2.0	3.4	3.4	2.1	1.8	1.4	0.3	5.5	0.9	1.2	1.3	1.1	7.1	6.9	6.5	7.4	5.5	2.9	8.1	4.5	7.1	6.3	11.9	1.4	2.4	4.3	3.1	0.4	2.5	7.6	4.0	5.7	3.5	0.0	39.3	0.0	6.5	1.4	6.3	0.1	0.0	4.3	26.3	14.6	2.6	4.6	2.6	7.9	1.6	2.4	15.4	5.1	0.9	16.4	4.3	5.0	2.8	1.7	9.3	4.6	0.0	11.0	1.0	0.6	6.5	5.6	8.0	1.6	2.3	11.3	5.4	1.5	1.0
CHST15	"BRAG, GALNAC4S-6ST, KIAA0598"	ENSG00000182022	"Carbohydrate sulfotransferase 15"	Q7LFX5	10	124007666-124093607	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 49.7;Kupffer cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 29.4;monocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 27.6;REH: 36.3;U-266/70: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017584	Approved		Approved	Centrosome,Cytosol		NA	NA		560000	Cytosol	Centrosome	"HPA017584: AB_1849437"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.62e-3)"	"unprognostic (7.90e-2)"	"unprognostic (8.16e-2)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (6.47e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.63e-3)"	"unprognostic (5.26e-3)"	16.4	10.0	8.7	17.0	20.6	5.7	10.7	3.4	17.9	9.8	15.4	6.6	4.0	8.8	8.6	10.8	11.3	13.1	11.7	6.4	11.3	5.3	9.0	11.9	13.9	35.4	6.5	9.6	35.0	12.6	2.9	7.7	5.9	9.2	8.5	8.3	14.4	8.2	13.4	11.0	8.3	12.5	9.5	9.0	31.5	11.4	4.8	8.7	2.8	19.3	6.1	12.6	12.5	12.0	2.1	2.0	29.4	15.4	0.0	0.1	3.2	12.8	8.7	3.2	0.7	3.2	1.7	0.0	2.6	3.5	1.4	2.0	0.2	7.0	0.0	8.5	10.7	0.9	14.7	0.6	8.5	1.2	0.0	2.4	0.0	3.9	6.4	1.0	0.0	16.6	1.0	9.8	4.0	3.4	3.5	2.8	0.0	0.0	27.6	7.0	7.1	0.0	0.0	2.8	1.9	0.0	36.3	4.4	8.5	7.1	1.2	0.3	0.7	7.0	3.9	0.0	8.4	2.9	0.0	3.3	0.3	0.1	10.1	0.4	25.1	6.0	6.9	0.1	0.0	0.0	0.0	8.8	6.2	0.0	14.0	0.0	2.0	0.0	0.0	1.8	2.1	0.1	0.0	29.4	0.0	15.4	2.0	0.1	3.2	8.7	20.6	3.4	17.9	11.3	5.3	6.5	9.6	9.2	8.7	20.8	11.1	9.7	14.5	14.9	4.4	2.2	7.6	9.4	9.1	19.2	0.0	1.5	0.0	8.2	24.2	10.8	0.0	0.0	0.6	1.9	2.7	14.0	5.7	6.4	9.4	0.0	1.7	49.7	47.8	27.7	9.5	23.2	1.7	1.8	0.0	0.1	5.9	0.0	1.8	0.3	0.3	19.4	11.3	8.4	9.2	10.2	0.8	2.2	0.0	15.2
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964365-72013564	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 14.7;Leydig cells: 19.0;Peritubular cells: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 28.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		510000	"Golgi apparatus, Cytosol"		"HPA047523: AB_2680075, HPA055704: AB_2682891"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	22.2	11.6	9.2	7.0	19.4	0.7	12.0	2.9	11.6	10.4	9.0	19.4	4.8	1.7	13.7	7.4	8.4	13.6	6.2	11.9	11.3	5.1	8.6	1.8	6.3	2.2	30.1	5.5	25.0	6.1	1.9	4.0	10.0	15.6	10.7	3.3	5.7	6.3	19.5	13.6	7.1	4.0	21.0	16.2	2.9	11.6	19.4	25.2	0.5	7.3	4.8	2.2	7.5	18.5	0.2	0.3	0.8	0.1	0.1	0.2	0.0	6.8	7.4	3.8	9.3	17.3	6.8	0.1	14.5	13.9	8.9	6.0	6.4	13.7	0.0	10.0	17.0	7.2	8.9	3.3	9.9	7.2	0.2	2.5	0.0	12.8	6.1	8.8	0.0	0.0	9.4	11.5	8.8	12.1	17.4	2.6	0.3	2.0	0.0	9.4	0.2	0.0	0.0	1.6	0.2	2.4	0.0	4.6	0.0	12.6	7.0	0.2	3.8	11.0	0.2	10.6	4.8	0.8	1.4	5.4	11.0	12.7	18.3	28.8	0.0	0.0	0.0	8.0	0.0	7.7	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.8	0.1	0.0	0.3	0.1	0.0	9.2	19.4	2.9	11.6	11.3	5.1	30.1	5.5	15.6	25.2	0.0	3.4	0.0	4.0	2.5	0.0	8.9	5.1	1.4	3.4	7.0	0.0	3.5	3.3	8.2	0.4	3.6	0.0	0.0	2.4	2.2	5.7	3.7	1.1	0.0	0.7	0.0	0.0	14.7	0.6	2.1	19.0	0.4	8.5	1.0	0.0	6.6	7.7	0.0	20.5	2.8	0.0	6.5	9.6	0.5	0.7	2.0	0.9	0.0	0.0	1.4
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573784-46598408	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 91.0;Peritubular cells: 56.6;Sertoli cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.4"	"Group enriched"	"Detected in many"	10	"granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 18.0;HHSteC: 13.4;NTERA-2: 16.1;PC-3: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favorable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.1	7.5	4.9	3.8	6.6	4.7	12.1	4.7	10.3	10.5	4.4	3.6	2.5	2.2	5.0	4.1	4.2	3.2	10.7	25.6	4.1	4.0	3.6	11.0	5.4	3.7	4.5	4.7	27.0	3.4	2.4	3.4	5.9	3.6	3.9	2.2	1.4	2.7	3.7	4.3	5.4	3.3	3.5	1.9	17.1	3.4	3.6	1.8	2.4	4.2	1.4	2.0	4.1	8.7	1.0	1.0	9.4	8.0	0.4	15.4	1.6	4.1	3.5	3.0	2.7	8.6	6.0	0.1	5.8	4.2	1.5	2.1	0.9	1.6	0.0	18.0	2.4	1.0	3.1	2.9	1.0	1.3	2.4	6.3	0.8	0.3	3.1	13.4	1.4	0.1	2.1	0.9	2.9	2.4	2.7	4.8	1.9	0.0	3.7	1.1	1.9	0.5	1.8	16.1	0.3	13.4	2.7	2.5	7.5	4.2	0.1	6.9	2.7	0.8	0.2	0.7	7.9	1.0	0.3	1.1	4.9	0.5	2.6	2.7	8.7	1.8	1.3	5.4	0.0	0.3	1.2	1.9	0.6	1.4	5.9	1.3	1.0	5.3	2.5	1.0	0.6	1.1	1.0	9.4	0.4	8.0	0.6	15.4	1.6	4.9	6.6	4.7	10.3	4.1	4.0	4.5	4.7	3.6	1.8	0.0	1.9	3.7	1.7	11.0	0.8	5.5	5.1	1.4	1.2	1.8	0.0	3.4	1.7	2.2	0.0	9.8	1.0	0.0	2.2	3.5	12.2	3.3	0.0	2.9	10.3	3.2	0.0	17.2	8.6	0.0	17.5	7.9	13.5	91.0	2.3	3.8	1.9	1.1	56.6	1.1	0.7	51.8	10.3	0.5	1.2	11.5	1.1	7.5	0.7	1.4
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175723-101251932	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 72.5"	"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 69.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	23.2	15.6	14.4	14.6	13.7	15.7	17.7	8.5	11.1	17.7	6.5	9.6	8.6	4.9	15.6	11.6	9.1	14.1	19.0	19.0	11.4	7.5	9.0	8.1	20.6	12.4	15.3	5.5	21.9	6.0	5.9	8.7	72.5	12.9	13.6	7.0	12.1	9.8	10.1	7.3	13.7	6.8	16.4	11.9	18.4	9.3	10.8	13.5	8.3	9.7	9.2	8.7	14.3	20.0	1.9	1.5	8.7	2.4	1.2	3.2	1.0	2.8	3.5	11.9	6.0	6.2	8.4	7.9	6.9	6.1	8.4	8.6	3.0	2.3	6.8	4.1	11.5	5.5	7.9	7.9	8.8	9.3	7.6	3.9	13.5	4.0	3.5	7.7	20.5	14.0	7.7	7.4	7.2	6.6	9.6	9.9	3.1	4.9	69.8	6.3	2.4	2.8	14.1	13.7	5.5	2.5	6.4	12.0	10.1	5.8	5.6	2.1	11.3	7.3	3.6	12.5	10.2	4.1	25.5	8.3	13.8	7.9	6.5	14.5	12.4	28.6	4.0	10.7	19.5	10.2	0.0	2.4	5.1	2.9	1.5	3.1	1.7	1.8	3.1	1.5	1.9	1.0	1.9	8.7	1.2	1.6	0.9	3.2	1.0	14.4	13.7	8.5	11.1	11.4	7.5	15.3	5.5	12.9	13.5	0.0	17.8	6.2	17.2	51.4	9.0	7.1	2.5	10.7	11.4	15.7	5.9	5.6	1.7	4.4	0.7	37.9	0.9	23.3	1.9	19.4	44.1	15.0	24.4	4.9	14.0	36.5	2.9	57.7	14.0	1.3	50.9	17.6	25.3	1.0	3.4	9.1	4.6	3.4	44.2	1.9	7.3	45.3	68.0	3.9	7.2	54.6	11.6	8.7	3.1	8.5
CHSY3	"CHSY-2, CSS3"	ENSG00000198108	"Chondroitin sulfate synthase 3"	Q70JA7	5	129904472-130186634	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Ito cells: 4.9;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;ASC TERT1: 11.3;HSkMC: 7.4;TIME: 6.8;U-138 MG: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044612	Uncertain				"Intracellular and membrane"	NA	NA					"HPA044612: AB_10795883"	"unprognostic (3.43e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.83e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.08e-6)"	"unprognostic (5.22e-3)"	"unprognostic (9.93e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.74e-2)"	11.7	1.6	7.0	2.7	8.9	0.3	5.7	0.4	10.4	12.5	1.7	2.1	0.0	1.5	4.2	1.6	1.8	2.6	7.2	3.0	4.8	2.2	1.0	4.8	4.6	1.4	2.1	8.9	1.1	1.1	2.1	0.9	5.6	1.0	1.4	1.6	6.3	1.3	1.8	2.2	2.8	1.3	5.2	1.5	1.9	1.5	1.9	2.1	0.0	2.9	1.3	1.3	3.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.1	0.0	12.7	11.3	1.0	2.8	0.1	0.4	0.4	0.0	0.1	0.0	0.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	1.5	1.7	5.6	0.4	1.2	0.0	0.0	7.4	0.0	0.1	1.1	0.6	3.0	0.0	0.0	1.8	4.9	0.0	0.0	0.0	0.6	0.0	1.2	0.4	5.4	0.0	0.2	0.0	4.4	0.0	0.0	0.0	0.2	1.1	0.2	0.4	6.8	13.6	2.8	0.1	1.8	0.0	0.0	0.0	0.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	8.9	0.4	10.4	4.8	2.2	2.1	8.9	1.0	2.1	8.9	0.6	0.0	0.0	0.5	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.1	2.3	0.0	0.0	2.0	1.4	0.0	0.0	4.9	1.8	0.0	1.1	0.0	3.3	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	6.5	2.5	1.4	0.6	0.3	0.3	0.0	0.0	0.0
CSGALNACT1	"ChGn, CSGalNAcT-1, FLJ11264"	ENSG00000147408	"Chondroitin sulfate N-acetylgalactosaminyltransferase 1"	Q8TDX6	8	19404161-19758029	"Enzymes, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 57.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 41.5;Endothelial cells: 33.7;Glandular cells: 33.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 22.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 20.1;granulocytes: 10.3;T-cells: 25.5"	"Cell line enhanced"	"Detected in some"		"A549: 29.0;BJ hTERT+: 16.3;GAMG: 11.7;RPTEC TERT1: 20.3;U-2197: 18.5;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068462			Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"		"HPA068462: "	"unprognostic (8.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.17e-3)"	"unprognostic (9.78e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.02e-2)"	13.8	8.7	22.7	6.0	15.4	6.8	7.2	3.8	21.4	13.0	3.8	9.2	4.0	2.8	7.1	5.9	21.2	8.7	10.8	23.8	17.7	8.2	5.3	2.3	7.9	10.5	9.1	18.7	38.6	10.9	4.2	5.9	25.1	7.0	21.7	2.1	2.6	5.8	7.3	3.9	4.2	4.2	17.2	8.6	6.3	5.4	2.7	10.3	4.0	57.7	4.5	6.1	18.9	9.7	20.1	1.7	10.3	1.2	3.2	25.5	4.8	0.7	29.0	0.2	0.0	4.8	1.1	3.7	0.6	16.3	0.1	0.1	1.4	0.3	0.0	0.0	0.0	11.7	0.3	0.0	0.0	0.1	3.6	0.2	0.0	8.3	0.7	2.1	0.0	0.0	0.4	0.7	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	1.2	1.1	0.1	0.0	3.6	0.9	0.1	0.0	0.0	20.3	0.7	0.1	0.1	8.5	3.4	1.1	0.6	0.0	0.0	0.3	0.4	0.4	18.5	0.2	0.1	0.0	0.0	13.4	1.6	5.6	0.0	1.2	10.3	2.5	0.0	0.3	20.1	11.5	3.9	1.1	6.2	20.6	5.2	7.1	3.2	0.1	1.7	25.5	4.8	22.7	15.4	3.8	21.4	17.7	8.2	9.1	18.7	7.0	10.3	3.0	1.4	8.2	8.2	3.9	0.4	41.5	0.0	2.7	1.2	12.2	9.8	1.4	1.7	3.7	5.5	33.7	0.0	0.0	1.5	13.5	20.0	33.6	0.0	0.0	12.0	17.5	2.9	20.3	21.2	5.9	4.9	5.1	11.8	0.0	0.0	0.9	3.0	0.0	11.3	0.0	1.0	6.5	7.2	0.1	0.0	2.8	7.0	2.2	0.0	2.1
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138486-43185308	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 62.0;Macrophages: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	18.3	8.2	9.0	16.4	13.0	80.6	11.5	10.0	10.9	11.4	12.5	17.6	4.8	6.8	14.7	7.5	9.8	12.8	18.4	11.5	10.0	9.0	8.2	11.3	24.0	25.7	11.0	6.2	16.2	6.3	7.8	15.0	18.3	11.5	10.4	8.9	19.8	7.9	8.6	12.5	8.1	9.6	15.7	14.4	21.1	8.7	6.7	9.6	24.3	9.2	6.6	12.2	17.8	11.0	2.5	11.6	15.2	16.3	8.7	6.3	5.1	4.9	3.3	6.2	5.9	9.7	16.4	1.5	18.1	24.4	8.0	12.5	1.1	5.1	8.2	4.5	16.3	3.8	4.6	5.1	6.8	13.1	9.8	3.8	4.3	3.1	3.4	21.2	9.9	9.0	16.3	7.5	17.8	37.3	10.1	10.2	12.5	1.8	24.7	16.3	2.6	7.5	5.9	2.7	1.7	4.3	4.7	6.2	3.4	7.1	2.6	5.6	11.1	4.7	4.8	11.3	5.6	6.4	8.2	15.0	6.9	10.9	21.5	12.1	6.4	8.9	4.4	14.6	24.3	3.2	10.7	9.8	15.2	6.3	11.4	5.5	2.5	4.9	4.9	11.6	2.2	5.8	4.8	9.0	8.7	16.3	3.4	5.6	5.1	9.0	13.0	10.0	10.9	10.0	9.0	11.0	6.2	11.5	9.6	14.9	16.0	7.2	10.1	15.8	11.9	9.2	2.5	6.7	14.8	10.4	9.8	1.9	0.0	5.4	2.1	14.0	1.4	0.0	6.0	5.6	26.7	10.2	46.2	10.4	15.8	7.9	8.6	14.1	62.0	0.4	15.8	59.7	8.5	7.2	2.1	4.4	9.8	1.7	11.7	3.4	8.3	25.8	25.1	11.7	17.2	10.7	1.3	32.8	1.6	6.0
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: AB_2681746"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.5	2.3	7.9	7.4	21.5	14.2	9.0	12.5	29.4	15.7	23.1	0.0	3.0	0.3	1.1	21.8	15.8	20.3	1.1	29.4	20.6	10.9	4.8	0.7	3.4	0.1	24.0	0.5	0.5	30.1	12.7	17.4	17.1	8.2	9.2	2.7	0.2	4.8	7.5	0.3	1.4	0.6	4.2	0.0	0.6	1.8	7.3	5.0	10.4	0.7	2.6	2.0	12.1	0.0	0.3	5.7	0.1	1.2	3.4	15.9	4.6	3.9	10.0	1.0	0.3	0.5	8.4	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0	14.9	2.6	18.6	20.6	46.1	4.1	7.0	5.1	18.7	18.2	3.5	0.0	2.0	6.6	4.0	39.9	11.9	0.0	0.0	7.5	3.7	35.5	14.2	22.0	3.8	39.5	1.6	1.2	57.7	85.3	19.2	50.9	81.1	10.1	97.4	0.7	3.9	9.5	0.0	28.3	6.1	3.0	32.3	29.2	2.6	5.1	34.9	4.1	6.5	1.0	42.4
EXT1	"LGCR, LGS, ttv"	ENSG00000182197	"Exostosin glycosyltransferase 1"	Q16394	8	117794490-118111853	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Hereditary multiple exostoses, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 55.5;fHDF/TERT166: 56.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044394	Uncertain					NA	Yes		9600000			"HPA044394: AB_10963838"	"unprognostic (1.29e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.70e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.85e-1)"	13.8	11.9	5.8	20.5	4.6	2.1	16.5	7.3	7.4	13.3	17.1	4.1	8.7	23.2	11.5	12.5	11.2	8.8	19.3	14.4	4.6	3.1	8.8	66.4	19.9	8.3	3.0	6.8	10.4	17.9	7.1	6.4	15.6	4.8	9.8	16.0	13.2	9.8	13.3	4.2	12.3	32.0	16.8	4.3	20.1	11.5	5.0	2.7	8.7	12.0	10.3	7.2	11.0	18.5	0.8	1.7	1.2	4.5	0.7	2.4	1.0	17.3	5.0	7.6	3.0	13.7	11.1	3.5	32.5	55.5	24.0	22.1	5.2	1.7	0.3	14.6	56.1	17.9	11.0	3.3	19.1	33.8	6.5	5.6	0.7	4.7	4.1	6.4	0.0	1.2	6.9	5.1	29.1	26.8	30.1	14.7	1.6	0.4	4.8	11.1	1.4	0.8	0.0	2.4	9.2	6.5	0.0	2.8	0.5	9.4	6.3	2.4	2.2	5.0	2.3	4.8	20.2	3.2	0.2	19.5	20.2	18.6	18.6	9.5	2.8	2.7	1.6	18.8	0.0	5.4	0.3	4.4	0.2	0.2	4.5	1.3	0.8	0.5	0.6	1.0	0.1	0.5	0.9	1.2	0.7	2.2	1.7	2.4	1.0	5.8	4.6	7.3	7.4	4.6	3.1	3.0	6.8	4.8	2.7	17.9	5.9	1.4	18.7	48.7	21.1	6.2	28.1	5.3	6.8	7.0	13.7	5.2	0.0	34.9	1.3	16.6	42.3	0.0	17.2	3.2	32.1	10.0	6.9	22.6	2.2	9.5	4.6	17.8	28.9	1.6	16.1	5.4	18.6	5.4	20.7	6.0	21.6	14.0	33.9	5.0	24.5	0.0	28.1	0.5	4.3	41.4	10.2	2.2	21.2	17.9
EXT2	SOTV	ENSG00000151348	"Exostosin glycosyltransferase 2"	Q93063	11	44095549-44245429	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078409			Supported	"Golgi apparatus"		NA	NA		20000000	"Golgi apparatus"		"HPA078409: AB_2686884"	"unprognostic (5.87e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.77e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (5.36e-6)"	"unprognostic (7.07e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.36e-2)"	24.5	19.5	11.6	17.2	18.5	6.6	25.8	14.5	23.0	26.8	25.0	15.5	17.5	17.6	37.1	25.5	16.7	26.0	23.4	22.7	11.7	13.0	19.2	36.3	22.3	16.8	11.8	12.3	29.3	21.8	25.7	17.3	58.0	16.2	23.7	20.6	22.9	24.7	22.8	16.9	20.2	34.0	35.0	12.2	18.7	19.3	20.0	11.4	16.2	24.7	16.7	13.0	20.2	23.2	6.7	14.9	13.0	12.0	17.8	17.6	9.8	13.1	18.2	9.9	30.7	45.6	33.6	13.6	40.8	51.1	24.2	33.0	12.9	9.1	9.1	18.6	47.8	25.6	21.0	10.5	29.0	29.3	18.2	14.5	8.4	9.6	9.9	18.0	8.4	18.1	26.0	19.2	14.6	22.9	28.5	34.3	8.7	11.2	16.4	17.6	10.1	5.8	5.1	10.6	16.8	13.0	7.3	28.2	4.6	14.0	12.5	7.1	7.9	25.8	10.6	6.8	18.3	17.6	9.0	31.0	32.7	21.4	32.0	26.2	7.4	9.7	6.7	21.5	6.5	34.9	9.3	11.9	13.0	15.6	12.0	17.6	6.4	12.5	14.4	14.9	6.7	11.9	11.7	2.6	17.8	8.5	5.1	9.6	9.8	11.6	18.5	14.5	23.0	11.7	13.0	11.8	12.3	16.2	11.4	14.9	8.8	10.5	13.2	13.5	11.5	9.2	5.1	5.3	10.3	12.2	13.7	27.3	5.0	28.2	30.2	16.7	20.5	0.0	20.6	30.2	24.4	17.7	5.8	15.5	16.2	12.7	1.7	21.5	11.9	17.4	25.3	7.7	5.0	10.0	14.0	16.6	21.7	14.0	26.9	7.0	14.3	19.4	16.9	36.9	21.7	11.0	29.5	7.5	13.3	14.6
EXTL1	"EXTL, MGC70794"	ENSG00000158008	"Exostosin like glycosyltransferase 1"	Q92935	1	26019884-26036464	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	13	"melanoma: 21.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 58.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010726, HPA037749"	Approved		Approved	Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		68000	Centrosome	Vesicles	"HPA010726: , HPA037749: AB_10805350"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-2)"	0.6	2.1	15.3	0.6	9.5	0.5	2.0	1.1	21.1	1.3	0.6	1.4	0.0	0.7	2.5	0.7	1.5	1.7	1.2	6.0	12.7	3.7	0.7	0.5	0.7	0.8	3.7	7.9	2.3	1.0	0.5	0.5	1.0	2.9	1.2	0.6	2.7	0.8	0.9	20.5	1.6	0.7	2.9	2.7	2.2	0.6	1.0	0.8	0.0	0.9	3.2	0.6	0.9	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	58.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	15.3	9.5	1.1	21.1	12.7	3.7	3.7	7.9	2.9	0.8	0.0	0.0	0.0	0.0	0.1	6.2	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.4	1.4	0.0	6.8	0.0	0.0	0.6	0.0	0.0	2.5	0.0	1.4	0.0	0.3	0.2	0.2	0.0	0.8	0.0	0.0	0.0
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895998	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 175.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		83000000	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: AB_2686058"	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	7.5	23.0	9.8	4.1	19.9	1.7	10.4	14.7	22.8	13.4	8.7	8.1	9.9	4.5	16.7	13.1	6.0	10.1	10.3	8.2	9.5	13.3	11.2	10.0	7.6	3.4	14.0	12.0	18.8	7.7	17.5	18.7	21.8	20.1	12.3	7.1	8.6	6.0	11.4	5.3	5.9	4.6	15.4	11.4	5.4	6.2	9.7	16.3	6.4	9.3	5.0	3.4	9.0	6.2	2.1	7.4	3.3	1.1	5.3	5.6	1.9	5.2	2.7	20.1	21.0	22.3	16.5	12.8	9.0	14.9	7.1	15.9	2.6	4.0	5.8	8.8	8.3	5.6	5.1	7.3	7.7	14.4	11.8	5.1	7.1	9.7	7.2	7.3	11.0	3.8	19.5	2.7	14.2	2.8	15.0	25.9	7.4	8.9	0.7	17.9	2.7	5.8	6.1	25.3	4.7	6.1	4.2	20.7	4.7	7.6	4.0	8.3	23.6	6.9	1.8	16.2	15.3	4.3	5.0	10.8	17.8	10.5	11.4	9.5	6.2	5.5	3.6	28.3	11.4	5.8	3.3	0.8	0.0	5.6	1.1	2.8	1.9	1.9	3.7	2.5	2.1	2.1	4.8	0.2	5.3	0.9	7.4	0.0	1.9	9.8	19.9	14.7	22.8	9.5	13.3	14.0	12.0	20.1	16.3	11.9	5.9	2.2	11.4	7.6	20.3	9.7	10.2	29.4	14.8	14.0	33.4	175.5	10.0	5.2	19.7	10.8	2.0	0.0	1.8	25.1	33.5	5.4	17.3	14.7	21.3	3.2	9.1	15.4	7.0	27.2	23.3	3.6	21.9	10.0	3.9	18.6	2.5	2.9	32.5	10.8	17.8	12.9	16.5	29.8	8.1	7.0	62.1	6.9	6.3	3.0
EXTL3	"botv, REGR"	ENSG00000012232	"Exostosin like glycosyltransferase 3"	O43909	8	28600469-28755599	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025387	Approved					NA	NA					"CAB025387: "	"unprognostic (1.35e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.83e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (4.25e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.39e-2)"	12.1	19.0	15.4	7.9	19.5	4.0	11.6	14.8	26.9	11.3	10.5	16.2	8.8	6.3	15.0	7.9	14.0	13.7	9.6	34.6	15.4	13.4	8.5	6.7	10.1	5.9	11.6	18.1	12.2	13.0	26.1	13.8	15.7	12.9	10.2	6.5	15.2	8.8	14.8	20.7	13.5	6.8	19.8	11.7	9.3	9.6	14.3	10.8	5.4	9.2	8.7	5.9	12.2	9.5	0.8	2.4	10.0	2.3	1.0	3.6	1.5	19.4	14.7	32.9	16.9	9.0	9.3	7.2	14.7	14.9	9.4	7.9	12.5	7.0	5.3	21.3	17.9	13.4	13.1	15.1	24.2	10.1	3.8	8.3	7.4	7.4	6.3	5.2	3.6	21.3	10.4	16.4	7.1	6.6	8.4	20.0	8.0	6.8	6.8	7.3	3.7	6.5	2.4	22.3	6.5	6.0	7.9	14.1	3.0	16.1	12.6	7.0	12.3	6.2	3.9	8.4	10.8	3.7	4.5	15.2	12.3	29.0	11.3	12.4	3.7	7.3	6.0	10.3	4.5	10.9	4.0	2.0	3.3	3.6	2.3	2.1	0.6	1.3	1.9	2.4	0.8	1.1	0.9	10.0	1.0	2.3	2.3	0.8	1.5	15.4	19.5	14.8	26.9	15.4	13.4	11.6	18.1	12.9	10.8	3.0	4.1	0.8	2.1	4.4	14.9	21.3	5.1	2.7	2.3	1.8	23.6	3.3	3.3	9.0	14.8	6.4	2.8	0.0	9.2	15.1	5.8	4.1	5.7	6.6	3.7	7.9	4.1	6.2	5.3	6.4	9.2	3.3	5.0	1.8	2.2	5.8	9.7	3.1	13.4	3.2	14.7	25.8	6.2	4.3	7.0	2.6	1.8	5.0	2.4	2.1
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 58.4"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		78000	Mitochondria		"HPA040481: AB_2677004, HPA048216: AB_2680317"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	8.3	12.2	6.5	4.9	14.2	0.6	8.8	58.4	12.1	8.4	12.1	12.4	7.8	13.5	6.3	6.9	10.2	5.9	7.2	5.5	5.8	8.5	13.3	16.0	8.4	5.3	9.4	8.1	12.9	5.9	9.0	12.0	12.6	14.4	5.7	14.0	10.8	11.7	8.9	4.1	9.8	11.2	6.8	10.2	4.0	8.8	6.1	7.6	5.4	4.1	8.4	5.8	6.3	5.6	0.6	4.0	0.1	4.4	0.5	4.0	1.9	3.9	3.5	2.4	4.2	8.2	7.8	0.8	7.4	9.9	5.8	11.0	2.9	10.0	2.4	3.7	6.0	7.3	6.0	5.2	4.8	11.8	0.9	5.7	4.0	6.7	3.0	7.9	1.7	8.2	5.3	3.3	7.1	8.1	4.2	50.9	1.8	1.6	2.6	10.8	2.4	1.0	3.0	1.2	4.0	2.5	2.4	9.8	3.0	5.3	4.2	7.7	1.6	7.6	4.7	15.7	1.7	3.4	2.4	17.7	5.6	6.9	6.1	6.5	1.1	1.5	0.5	5.6	2.9	8.0	0.0	4.4	0.1	0.7	3.4	1.2	0.6	1.8	0.8	3.6	0.5	1.2	1.5	0.1	0.5	4.4	4.0	4.0	1.9	6.5	14.2	58.4	12.1	5.8	8.5	9.4	8.1	14.4	7.6	0.0	12.5	5.7	9.1	4.2	10.3	6.2	7.6	25.4	5.7	10.4	9.8	20.3	5.0	10.4	3.2	13.9	15.7	0.0	12.1	9.9	5.9	4.9	2.3	24.6	13.5	7.9	19.5	16.5	14.6	3.3	5.8	7.7	8.5	11.8	26.4	12.9	12.9	23.4	16.6	14.0	15.4	12.9	3.9	13.0	13.4	5.6	27.6	4.4	26.5	12.1
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914648-87109998	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.8	28.7	15.5	9.6	25.2	2.8	7.3	8.9	15.1	10.3	9.5	6.2	5.4	8.6	9.0	9.4	6.4	6.5	9.6	6.8	14.7	10.2	12.8	15.5	8.0	9.7	9.2	13.8	12.3	9.0	15.9	12.1	7.5	10.1	8.9	8.3	8.2	8.3	9.7	5.3	7.2	8.0	7.1	7.6	18.6	7.2	8.0	7.7	16.5	11.8	4.3	10.0	9.2	7.1	5.6	1.3	9.0	4.3	1.8	3.0	1.8	9.9	8.5	25.0	16.3	13.9	40.6	8.7	9.7	12.8	8.2	9.1	32.4	12.8	21.9	9.5	6.7	14.2	6.1	11.4	8.1	13.3	17.1	9.5	26.3	9.4	25.8	5.8	13.5	13.2	16.7	7.2	13.2	11.0	13.0	12.1	12.4	17.9	11.6	11.8	3.5	13.5	8.2	8.7	10.9	5.6	16.8	23.7	4.7	10.0	20.9	5.4	8.1	12.9	11.1	11.2	6.8	7.3	6.2	10.6	10.3	12.8	18.0	12.2	10.7	7.9	20.6	6.3	9.8	10.5	9.0	2.0	1.7	2.6	1.2	3.0	2.0	2.8	2.8	1.3	5.6	2.8	1.8	2.1	1.8	4.3	1.3	1.5	1.8	15.5	25.2	8.9	15.1	14.7	10.2	9.2	13.8	10.1	7.7	14.9	11.3	8.0	7.0	14.7	8.7	11.5	15.3	9.4	19.4	19.2	3.9	8.0	11.6	13.0	3.6	12.6	10.5	0.0	10.0	7.5	16.7	8.7	18.5	24.1	29.9	7.9	22.4	17.2	12.6	3.0	6.4	11.8	11.8	5.4	13.5	26.9	11.0	3.5	19.1	14.7	16.3	0.0	14.2	7.4	13.9	13.8	3.7	7.5	13.0	6.8
HS3ST1	3OST1	ENSG00000002587	"Heparan sulfate-glucosamine 3-sulfotransferase 1"	O14792	4	11393150-11429765	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;gallbladder: 31.9;ovary: 30.3"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 64.3;Club cells: 83.0;granulocytes: 93.6;Peritubular cells: 84.8;Urothelial cells: 90.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"cerebellum: 27.4;cerebral cortex: 9.0"	"Group enriched"	"Detected in some"	39	"memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3"	"Group enriched"	"Detected in many"	99	"B-cells: 15.8;dendritic cells: 22.3"	"Cell line enhanced"	"Detected in some"		"A-431: 4.5;CAPAN-2: 14.4;HaCaT: 4.3;RPTEC TERT1: 12.6;RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002237	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA002237: AB_1079085"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (3.32e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.99e-8)"	"unprognostic (9.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (8.67e-4)"	2.3	2.9	1.6	2.8	2.2	2.8	2.0	27.4	9.0	3.3	2.7	1.1	3.6	3.5	4.3	5.0	10.2	4.3	31.9	2.2	1.7	1.8	10.4	0.9	3.4	2.1	1.9	1.5	30.3	1.1	0.7	8.9	1.0	2.4	3.2	1.7	1.7	3.7	2.4	0.7	0.8	2.9	1.7	2.2	3.0	7.0	3.0	0.3	3.8	1.8	7.0	7.4	7.3	2.4	15.8	22.3	0.1	0.1	0.0	0.1	0.6	4.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.4	0.0	0.4	0.0	0.0	4.3	0.0	2.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.9	1.2	1.0	0.0	0.0	12.6	10.3	3.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	2.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	7.3	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.6	1.6	2.2	27.4	9.0	1.7	1.8	1.9	1.5	2.4	0.3	3.0	8.0	2.2	9.8	8.0	1.5	2.4	15.3	64.3	83.0	19.2	3.9	0.5	0.0	17.1	0.8	23.4	3.0	0.0	1.8	31.9	5.0	4.1	93.6	0.0	37.3	1.6	2.4	9.2	2.7	0.8	8.1	9.0	1.7	7.2	5.6	39.8	32.0	2.6	84.8	3.7	2.2	0.0	6.4	6.0	5.5	7.0	1.1	0.9	3.7	90.2
HS3ST2	3OST2	ENSG00000122254	"Heparan sulfate-glucosamine 3-sulfotransferase 2"	Q9Y278	16	22814177-22916338	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 12.7;brain: 38.2;lung: 13.4"	"Cell type enhanced"	"Detected in some"	17	"Basal keratinocytes: 3.2;Bipolar cells: 3.5;Hofbauer cells: 13.5;Peritubular cells: 5.3;Smooth muscle cells: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 10.5;SH-SY5Y: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017736	Approved					NA	NA					"HPA017736: AB_1851095"	"unprognostic (4.09e-2)"	"unprognostic (2.90e-3)"	"unprognostic (5.97e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (1.35e-4)"	"unprognostic (4.89e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.00e-2)"	12.7	1.7	3.8	1.1	6.5	1.1	2.4	0.5	38.2	2.0	1.4	0.3	0.3	1.0	1.0	1.0	1.2	1.0	1.1	3.8	7.8	4.3	1.0	2.2	13.4	2.1	2.2	8.4	4.5	1.0	1.0	0.4	1.2	1.5	2.0	1.4	5.0	2.9	1.1	1.0	2.0	1.0	1.2	1.0	1.1	1.1	1.1	0.0	0.0	1.8	0.4	1.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	6.5	0.5	19.1	7.8	4.3	2.2	8.4	1.5	0.0	0.0	0.0	0.0	0.1	3.2	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	13.5	0.0	0.0	0.6	0.6	0.7	1.1	0.4	0.0	0.0	0.0	0.0	0.6	0.0	5.3	0.0	0.6	0.0	4.1	0.0	0.0	1.8	0.2	0.0	0.0	0.7
HS3ST3A1	"30ST3A1, 3OST3A1"	ENSG00000153976	"Heparan sulfate-glucosamine 3-sulfotransferase 3A1"	Q9Y663	17	13495689-13601927	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Horizontal cells: 25.4;Ito cells: 8.0;Leydig cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.0;cerebral cortex: 2.2;pons and medulla: 3.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.9;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.2;U-251 MG: 47.9;U-87 MG: 29.7"									"HPA062518, HPA071530"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA062518: AB_2684789, HPA071530: AB_2686411"	"unprognostic (2.88e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.12e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-9)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.70e-3)"	1.3	3.3	0.2	2.8	1.0	1.5	2.3	0.1	2.2	7.8	1.6	0.3	5.8	2.3	3.3	1.3	8.1	1.9	1.3	3.8	0.3	0.2	1.7	3.4	2.2	9.3	0.1	0.4	12.1	0.4	0.0	1.2	6.8	3.0	9.9	0.5	2.0	3.3	8.6	0.9	1.1	1.7	0.4	1.3	11.7	1.0	2.9	0.0	0.6	0.6	6.3	12.7	1.4	5.3	0.1	3.9	0.5	0.1	0.7	5.1	0.8	0.0	0.1	1.2	0.0	0.8	2.2	2.0	7.7	1.6	1.3	0.8	0.0	0.2	0.0	1.0	4.2	0.0	0.0	0.0	0.0	1.0	0.4	7.9	2.0	0.6	0.7	0.6	0.0	0.5	2.0	0.0	3.4	0.7	1.7	0.0	0.1	7.6	0.0	1.3	1.0	0.0	1.3	1.4	0.0	17.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	1.2	0.1	0.0	47.9	0.0	0.0	0.0	29.7	0.0	3.6	0.0	0.0	0.0	1.7	0.0	0.8	0.0	1.2	1.4	0.0	0.1	1.4	1.4	0.5	0.7	0.1	3.9	5.1	0.8	0.2	1.0	0.1	2.2	0.3	0.2	0.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.2	25.4	0.0	8.0	1.0	0.0	12.7	0.0	0.0	0.0	0.0	1.0	0.7	0.0	2.1	0.0	0.1	0.0	1.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301083-14349404	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 37.3;Hepatocytes: 32.1;Ito cells: 34.4;Syncytiotrophoblasts: 30.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;pons and medulla: 6.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 20.6;T-cells: 14.7"	"Cell line enhanced"	"Detected in many"		"AF22: 15.5;BEWO: 11.1;Hep G2: 13.5;HSkMC: 15.4;U-251 MG: 14.2"									HPA064126			Approved	Vesicles		NA	NA			Vesicles		"HPA064126: AB_2685194"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	1.4	1.4	0.6	8.7	0.8	1.3	3.0	0.9	2.7	3.8	1.8	0.0	0.8	1.4	1.0	0.3	2.8	1.7	2.6	2.0	0.6	0.7	3.6	29.1	3.7	26.6	0.6	0.0	4.7	1.3	0.4	1.4	33.5	6.0	2.4	1.9	5.3	12.6	2.5	1.8	2.2	2.5	0.6	2.9	4.9	1.4	0.7	0.0	13.2	1.5	2.5	5.9	1.5	5.3	0.4	20.6	0.5	0.4	3.8	14.7	2.7	0.0	0.3	15.5	0.0	4.7	5.3	11.1	4.4	6.4	4.0	4.2	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.4	2.4	2.0	1.3	3.2	0.3	2.0	13.5	6.2	0.5	2.3	15.4	0.8	1.4	3.7	0.9	0.0	0.8	4.6	0.0	3.2	0.8	0.7	0.6	0.5	0.1	0.4	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.3	0.4	0.0	3.9	0.0	0.0	14.2	0.0	0.0	0.0	3.0	0.0	0.9	0.1	0.2	0.0	6.3	0.4	5.0	0.4	7.6	4.9	0.4	0.4	7.7	7.5	0.5	3.8	0.4	20.6	14.7	2.7	0.6	0.8	0.9	2.7	0.6	0.7	0.6	0.0	6.0	0.0	0.0	0.6	1.4	0.2	10.2	2.0	2.2	2.5	4.0	1.2	7.0	37.3	5.1	0.0	0.6	11.1	2.5	0.0	0.0	0.2	10.4	9.0	0.7	0.0	32.1	1.4	7.9	0.0	34.4	3.7	1.4	2.6	4.3	1.7	1.8	0.0	6.0	0.1	0.0	1.1	0.0	15.2	12.9	2.7	0.6	0.4	12.9	30.3	11.7	0.0	0.1
HS3ST4	3OST4	ENSG00000182601	"Heparan sulfate-glucosamine 3-sulfotransferase 4"	Q9Y661	16	25692026-26137688	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 23.9"	"Cell type enriched"	"Detected in single"	8	"Bipolar cells: 5.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.5;SCLC-21H: 2.3;SuSa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.95e-1)"		"unprognostic (2.24e-1)"	"unprognostic (1.43e-3)"		"unprognostic (1.27e-1)"		"unprognostic (3.84e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.71e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.67e-2)"	0.7	0.8	6.9	0.6	9.3	0.6	5.1	6.8	23.9	1.1	0.6	2.6	0.0	0.6	0.7	1.3	0.9	0.7	0.6	0.6	11.5	10.0	0.7	0.6	0.6	0.6	5.9	10.8	0.7	0.6	0.6	0.1	0.6	14.3	2.0	0.6	0.3	0.8	0.6	0.6	0.7	0.6	0.6	2.2	3.7	1.1	1.3	1.5	0.0	0.6	0.0	0.8	1.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	9.3	6.8	13.4	11.5	10.0	5.9	10.8	14.3	1.5	0.0	0.0	0.0	0.4	0.0	5.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 5.0;Collecting duct cells: 10.4;Cone photoreceptor cells: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 5.0;RT4: 9.2;SCLC-21H: 17.8;U-266/70: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved					NA	NA					"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.5	1.9	3.3	0.9	13.1	1.3	0.5	0.6	11.9	0.8	1.0	9.1	3.5	0.7	0.8	0.5	0.6	0.6	0.7	0.5	4.2	3.5	0.9	0.5	1.1	0.5	6.1	2.7	0.6	1.3	0.5	0.3	0.6	7.8	0.7	0.9	0.6	0.7	9.4	10.1	1.3	1.2	0.9	7.5	0.5	1.2	0.9	8.0	0.0	0.6	0.0	0.5	2.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	2.5	5.0	0.0	1.0	0.0	0.0	9.2	17.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.1	4.5	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.3	13.1	0.6	5.7	4.2	3.5	6.1	2.7	7.8	8.0	0.0	0.0	0.0	0.0	1.1	5.0	0.7	0.0	0.0	0.0	10.4	17.7	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.2
HS3ST6	HS3ST5	ENSG00000162040	"Heparan sulfate-glucosamine 3-sulfotransferase 6"	Q96QI5	16	1911463-1918440	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.8;skin 1: 15.0"	"Cell type enhanced"	"Detected in some"	15	"Horizontal cells: 20.6;Suprabasal keratinocytes: 8.0;Urothelial cells: 17.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 2.8;HaCaT: 2.8;U-2 OS: 1.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.72e-2)"	"prognostic favorable (3.73e-4)"		"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"		"unprognostic (1.19e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.99e-3)"		"unprognostic (2.10e-2)"		"unprognostic (6.55e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.26e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.1	6.6	0.4	0.0	0.4	0.0	0.3	0.9	18.8	1.2	0.0	0.1	0.1	0.1	0.2	0.1	1.9	0.1	0.1	0.0	0.5	0.1	0.0	0.2	1.9	0.0	3.6	0.0	0.6	0.4	0.1	0.3	15.0	0.1	1.0	0.1	0.1	0.1	0.1	0.0	2.1	0.1	2.7	3.2	6.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.3	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.2	4.1	1.4	0.0	0.0	0.2	20.6	0.0	0.0	0.0	0.7	0.0	0.0	3.3	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.0	0.1	0.0	0.8	17.7
HS6ST1	HS6ST	ENSG00000136720	"Heparan sulfate 6-O-sulfotransferase 1"	O60243	2	128236716-128318577	"Disease related genes, Predicted intracellular proteins"		Transferase	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 71.5;granulocytes: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 39.5;HMC-1: 62.8;SCLC-21H: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044586			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		27000	Nucleoplasm		"HPA044586: AB_10963057"	"unprognostic (9.94e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.94e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	13.2	32.0	22.4	8.0	16.2	4.1	9.2	17.2	33.2	16.2	9.6	13.5	23.8	8.3	8.8	6.4	19.3	17.1	20.1	8.1	17.3	13.9	22.8	29.5	9.1	7.1	17.8	18.8	16.2	24.2	8.9	7.5	11.5	16.5	13.1	6.9	10.5	12.2	23.9	20.1	14.2	11.3	6.4	14.9	18.2	6.3	14.7	15.6	10.9	7.0	6.7	8.0	19.1	11.1	2.0	5.5	5.8	3.0	0.5	2.6	1.2	3.5	5.2	14.0	8.0	5.4	10.2	7.5	4.4	5.7	4.5	2.5	2.6	2.4	3.5	39.5	5.7	2.1	9.6	5.3	8.7	1.7	5.7	5.4	3.0	1.9	25.6	6.6	5.3	62.8	13.7	10.3	3.6	1.1	1.5	2.4	9.5	1.9	3.6	1.6	7.5	14.1	23.5	16.7	1.4	3.2	4.6	3.8	18.0	4.1	10.8	34.4	8.6	3.6	9.1	2.0	9.8	3.7	2.0	2.8	4.0	8.9	14.8	3.5	2.1	2.1	0.7	2.4	3.8	2.9	5.8	1.6	1.4	2.6	1.0	0.4	1.9	1.0	1.6	1.1	2.0	1.0	1.0	0.5	0.5	3.0	5.5	0.5	1.2	22.4	16.2	17.2	33.2	17.3	13.9	17.8	18.8	16.5	15.6	23.8	12.8	5.2	10.5	14.3	8.1	6.1	7.6	10.7	9.1	71.5	29.5	7.4	5.0	10.2	0.8	7.7	7.1	0.0	5.1	34.4	11.6	6.8	54.4	15.1	8.6	20.6	2.9	30.7	11.7	2.0	10.9	6.2	6.8	6.4	5.2	7.8	7.9	8.2	15.9	2.8	33.7	6.5	5.1	1.1	3.1	14.9	19.5	2.5	4.1	7.8
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5;kidney: 17.3;ovary: 18.2"	"Cell type enhanced"	"Detected in some"	16	"Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 29.5"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5"	"Low region specificity"	"Detected in all"							"HPA034625, HPA034626"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034625: AB_10612119, HPA034626: AB_2674252"	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.03e-4)"	0.4	3.2	6.5	0.9	29.5	0.1	2.6	3.0	6.7	1.0	0.8	0.8	0.6	0.3	4.5	3.2	5.0	2.5	0.5	0.4	4.1	9.1	17.3	0.2	1.0	0.3	3.5	0.9	18.2	6.5	0.1	1.3	9.9	3.3	5.4	1.2	0.0	1.1	1.6	6.7	0.3	0.2	2.0	3.3	0.2	1.1	7.9	0.7	0.7	0.6	1.7	2.7	2.3	0.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	4.3	0.0	6.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.1	0.0	0.0	6.5	0.0	0.0	0.2	9.2	0.0	0.0	0.0	19.6	0.0	13.3	0.0	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.2	0.1	0.0	5.0	3.0	0.2	0.0	28.4	0.0	5.7	14.1	0.7	35.5	6.2	0.0	0.0	10.7	0.0	0.0	0.0	0.0	1.1	4.1	9.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.5	29.5	3.0	5.8	4.1	9.1	3.5	0.9	3.3	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.0	13.4	7.9	3.5	0.0	31.0	5.0	0.0	0.4	0.4	0.0	0.0	1.6	1.3	2.2	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	58.1	0.0	0.0	0.0	0.0	5.3	1.2	0.0	33.2	0.0	0.0	0.0	0.3	0.2	1.2	0.3	14.5	0.0	0.0	0.2
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090839-96839562	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.7"	"Cell type enhanced"	"Detected in some"	13	"Horizontal cells: 3.2;Pancreatic endocrine cells: 1.0;Rod photoreceptor cells: 1.8;Spermatogonia: 1.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 19.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		9800	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	0.9	4.5	1.5	0.0	1.9	0.0	0.0	0.4	18.7	1.9	0.0			0.2	2.1	2.2	0.2	0.1	0.0	0.2	3.2	2.7	0.7	0.0	0.0	0.0	0.9		0.0	2.1	0.0	0.7	0.0		0.1	0.0		0.0	0.1	0.6	0.1	0.0	1.6	0.4	0.0	0.7	0.1			2.4		0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	19.6	1.0	0.8	0.1	0.1	0.0	0.3	0.6	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0
NDST1	"HSST, NST1"	ENSG00000070614	"N-deacetylase and N-sulfotransferase 1"	P52848	5	150485818-150558211	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"dendritic cells: 5.5;granulocytes: 7.2;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060532	Approved					NA	NA		1000000			"HPA060532: AB_2684310"	"unprognostic (1.36e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.08e-2)"	26.3	15.5	17.3	9.9	20.2	4.9	21.3	8.6	28.3	12.9	10.2	41.7	7.3	9.3	11.8	10.0	25.5	11.0	16.9	19.6	17.9	14.4	11.4	49.2	25.2	6.1	28.5	13.8	17.3	28.9	16.5	4.7	10.0	26.1	11.3	7.3	10.8	25.4	13.5	15.3	24.9	14.7	14.3	32.8	30.1	10.2	12.6	19.6	1.4	17.3	11.9	9.8	10.5	11.5	0.6	5.5	7.2	6.5	0.1	0.6	2.9	9.8	8.8	14.6	17.8	14.7	14.7	14.7	18.1	23.9	18.1	27.3	25.9	10.4	6.7	18.4	36.1	29.1	16.9	7.8	36.7	12.1	0.8	12.2	7.9	5.7	4.0	10.9	5.9	14.5	20.0	15.3	21.8	9.9	18.2	24.6	4.0	7.5	2.4	17.6	8.3	0.7	1.8	6.8	2.7	10.4	11.4	12.2	2.9	10.6	10.0	4.4	15.4	10.9	34.3	14.5	10.9	18.3	1.4	12.0	31.0	28.1	13.4	14.8	5.4	1.4	2.5	25.4	9.2	11.9	1.7	6.5	4.4	0.1	2.3	0.0	0.6	0.0	0.6	5.5	0.1	0.1	0.2	7.2	0.1	5.5	0.4	0.0	2.9	17.3	20.2	8.6	28.3	17.9	14.4	28.5	13.8	26.1	19.6	35.7	8.3	0.8	2.4	5.0	11.1	10.4	15.3	0.0	7.9	15.7	7.9	7.4	1.7	8.2	0.4	12.6	12.1	0.0	8.9	9.2	10.0	6.0	1.1	42.9	7.0	12.7	1.2	35.0	17.9	1.5	11.5	5.0	10.1	1.0	6.3	12.2	13.6	5.8	30.1	8.4	10.1	0.0	7.1	0.0	0.6	10.8	3.8	1.0	4.4	3.5
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.8"									HPA051515	Approved		Approved	Cytosol		NA	NA		72000	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	12.6	14.6	7.9	19.2	11.3	37.5	11.8	30.2	12.2	16.6	10.7	13.8	13.4	8.9	18.4	14.8	14.4	12.8	15.5	9.3	9.6	8.4	11.0	9.4	14.7	21.9	7.3	8.8	15.1	12.3	17.3	26.5	14.1	9.2	13.6	10.5	14.7	20.1	17.2	16.4	15.1	14.4	13.4	7.5	31.8	11.8	13.5	9.2	35.3	12.2	8.2	19.3	12.3	13.3	3.1	6.8	5.8	5.3	2.2	7.1	3.2	4.3	3.6	7.5	11.5	9.3	10.8	3.9	5.1	10.9	5.9	6.1	1.9	5.3	3.9	3.1	9.7	6.0	5.0	3.7	5.4	4.8	10.4	3.6	3.9	2.7	3.0	16.4	5.0	50.8	10.2	6.6	10.2	10.5	18.4	7.7	7.9	3.7	15.1	7.4	3.3	5.8	5.5	2.1	2.7	15.3	3.6	3.7	2.4	5.0	3.0	2.5	4.2	4.5	10.7	3.5	5.2	8.2	7.7	12.3	3.0	3.5	3.9	3.6	7.5	3.3	5.2	3.5	7.7	2.3	1.4	5.3	2.1	5.5	3.7	6.5	2.5	4.7	4.8	4.0	3.1	5.6	7.1	5.8	2.2	3.5	6.8	3.1	3.2	7.9	11.3	30.2	12.2	9.6	8.4	7.3	8.8	9.2	9.2	0.0	4.8	3.7	0.3	1.1	0.6	1.4	0.0	4.0	2.3	0.0	0.0	1.2	0.0	4.4	5.7	0.5	3.5	0.0	8.4	1.4	1.0	1.5	13.9	3.8	4.5	1.6	2.4	0.0	6.7	6.8	0.0	3.5	1.7	4.6	2.3	0.7	5.5	2.6	0.0	5.6	0.7	0.0	1.0	2.4	1.4	1.4	5.1	3.2	1.7	2.1
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258648	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 20.2;Horizontal cells: 6.4;Kupffer cells: 27.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	10	"MOLT-4: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain					NA	NA					"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.3	2.0	3.2	0.3	17.0	0.6	0.3	22.2	6.9	2.1	0.4	0.0	0.0	0.3	0.4	0.2	0.3	1.3	0.4	0.3	2.3	2.0	0.9	4.6	0.4	0.6	0.9	1.7	0.6	0.2	0.2	7.6	0.4	1.7	0.5	0.4	1.3	0.2	1.2	0.3	0.4	0.4	0.4	0.6	6.8	1.0	0.5	2.4	6.8	0.6	0.0	0.4	0.3	0.3	0.3	0.4	1.3	0.2	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.9	1.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.3	0.4	0.1	0.4	0.0	0.0	3.2	17.0	22.2	5.7	2.3	2.0	0.9	1.7	1.7	2.4	0.0	0.0	0.0	0.0	0.0	20.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.4	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	17	"pons and medulla: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011129	Uncertain					NA	NA					"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.1	0.0	1.3	0.0	1.7	0.0	0.1	0.2	3.4	1.4	0.3	0.3	0.3	0.1	1.5	0.0	0.1	0.1	0.3	0.1	0.7	1.9	0.1	0.0	0.1	0.0	1.3	1.4	5.7	0.1	0.0	0.6	0.0	34.6	1.5	0.1	0.0	0.5	0.6	0.1	0.2	0.1	1.6	1.0	2.5	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.2	1.7	0.7	1.9	1.3	1.4	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747328-149076990	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 17.0;Muller glia cells: 13.3;Peritubular cells: 10.6;Suprabasal keratinocytes: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA					"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	8.6	16.0	4.8	7.1	9.3	0.8	8.5	20.9	10.8	12.8	8.6	6.0	6.6	2.6	10.8	8.1	8.2	10.4	12.2	4.5	6.3	12.6	5.2	2.2	8.6	4.9	14.1	4.5	15.6	19.0	0.7	2.3	6.1	13.0	9.8	4.0	10.7	4.3	6.9	3.7	8.6	5.6	11.5	9.1	8.0	5.7	12.1	6.5	3.1	37.5	5.7	4.9	10.6	21.0	1.5	1.3	0.1	0.9	6.2	1.7	0.4	0.0	2.1	12.0	9.2	14.6	12.2	0.1	5.1	13.4	2.5	6.5	0.0	0.8	4.2	1.1	7.9	6.3	3.7	8.5	4.3	5.1	5.6	6.4	0.1	6.8	0.1	5.4	0.2	1.8	6.2	9.7	6.5	12.1	5.1	0.1	7.1	0.0	0.0	2.0	5.3	0.0	0.0	7.0	20.7	2.7	2.0	1.6	4.9	0.1	9.6	6.2	0.0	17.0	4.2	3.1	9.0	3.1	0.2	0.2	7.3	0.8	1.6	4.5	0.0	0.0	0.0	8.1	3.4	4.1	0.0	0.2	0.0	1.7	0.7	1.4	0.8	1.3	1.5	1.1	1.5	0.1	0.7	0.1	6.2	0.9	1.3	0.4	0.4	4.8	9.3	20.9	7.4	6.3	12.6	14.1	4.5	13.0	6.5	3.0	2.7	0.5	4.2	8.4	0.0	1.2	0.0	1.4	1.2	1.8	0.0	1.4	0.0	0.1	0.6	0.1	0.0	0.0	1.7	0.2	8.1	4.2	0.0	0.0	1.4	0.0	0.0	2.5	1.3	2.6	17.0	1.1	5.0	1.0	1.4	13.3	1.5	0.0	10.6	0.4	0.4	0.0	2.2	1.7	3.2	10.2	1.1	1.5	0.6	6.8
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 92.3;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		30000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.7	0.0	19.2	11.9	3.3	8.5	4.3	1.0	0.4	0.2	0.2	2.1	0.0	10.3	0.3	0.2	0.0	1.7	1.5	4.1	0.2	2.6	0.0	0.0	0.2	3.7	3.5	4.4	0.2	5.5	0.8	1.6	0.0	0.2	0.3	8.0	1.0	0.3	0.0	4.0	2.9	1.4	0.0	1.2	0.0	0.4	0.0	3.9	0.7	5.2	0.6	2.6	0.5	2.1	0.7	2.3	0.0	9.0	1.0	19.7	0.0	9.0	0.5	3.9	10.0	4.2	7.6	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1	3.0	4.5	7.5	1.5	7.0	13.3	2.7	0.0	0.0	1.2	0.0	92.3	9.8	0.0	1.2	0.4	2.2	5.1	0.0	1.4	16.8	16.2	3.4	2.3	0.0	3.3	0.0	12.1	2.5	8.5	0.4	11.8	8.0	3.3	2.8	3.8	1.3	2.6	7.0	47.0	0.2	4.1	6.5	5.7	0.2	2.5	16.2	11.0	4.4	6.5	4.2
XYLT2	"PXYLT2, XT-II"	ENSG00000015532	"Xylosyltransferase 2"	Q9H1B5	17	50346092-50363138	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 53.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 305.8;Late spermatids: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		990000				"unprognostic (1.52e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-2)"	6.9	8.5	5.8	11.3	10.6	4.1	7.4	10.3	10.9	10.7	9.2	5.4	15.8	10.0	9.6	12.2	8.5	10.4	14.9	9.4	5.3	4.8	9.2	6.1	6.1	10.2	4.7	8.8	11.8	13.5	9.1	5.8	9.0	5.4	12.1	3.9	13.1	12.7	11.7	7.9	15.6	6.9	17.0	3.8	8.4	53.4	5.8	3.7	10.2	9.5	6.7	10.4	11.7	9.0	5.3	4.9	6.6	4.0	7.8	7.8	4.3	9.9	12.7	3.5	2.9	4.9	4.8	9.1	9.3	8.6	8.4	9.5	13.5	7.5	5.2	23.7	8.3	7.4	7.7	1.1	13.1	1.7	25.7	9.1	11.7	3.9	5.8	6.7	3.6	6.3	6.5	8.1	6.7	3.1	8.4	7.1	4.6	2.0	4.3	5.5	13.0	6.7	5.0	3.1	6.6	9.0	3.4	10.2	4.3	4.7	5.2	1.9	4.4	6.2	5.9	9.8	4.1	28.2	3.5	8.4	19.2	9.8	10.4	8.3	23.9	10.9	1.8	20.3	5.9	5.2	6.6	4.0	3.2	5.9	2.8	6.3	2.9	5.9	7.8	4.9	5.3	6.0	5.3	4.7	7.8	2.5	3.4	5.2	4.3	5.8	10.6	10.3	10.9	5.3	4.8	4.7	8.8	5.4	3.7	8.9	6.7	4.2	4.0	5.0	8.2	6.4	15.3	0.0	2.3	1.8	27.5	6.0	0.0	6.2	305.8	7.4	4.2	0.0	5.5	4.7	9.1	1.4	1.1	7.2	3.4	6.4	10.4	8.6	4.1	85.8	11.5	3.8	6.8	1.8	9.9	5.7	5.8	0.0	16.3	2.1	5.6	25.8	7.2	1.4	4.5	2.8	1.3	3.1	11.8	0.6
